Genomic biomarker testing
Helomics offers a select group of clinically relevant protein expression and genetic mutation tests associated with drug response and disease prognosis. Only well-validated tests are included in our biomarker menu with citations of supporting literature provided in every test report.
Panels are available for gynecologic and all other solid tumor types and can be ordered by individual biomarker.
Helomics genomic biomarkers include:
Results are available within 10-14 days of receiving a signed test order form.
Utilizing biomarker results
Helomics biomarker results are presented in a clear, easy-to-understand format, including summaries of the clinical relevance of each test. Each patient report is delivered within 10-14 days of receiving a signed test order form.